Dr Subhaschandra Reddy Ravi, MD | |
30 W Main St, Hartford, MI 49057-1005 | |
(269) 621-2166 | |
(269) 621-2566 |
Full Name | Dr Subhaschandra Reddy Ravi |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 30 W Main St, Hartford, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043379803 | NPI | - | NPPES |
3508062072 | Other | MI | BCBS OF MICHIGAN |
11286631 | Other | MI | CAQH |
1790118 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 4301037460 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Subhaschandra Reddy Ravi, MD 30 W Main St, Hartford, MI 49057-1005 Ph: (269) 621-2166 | Dr Subhaschandra Reddy Ravi, MD 30 W Main St, Hartford, MI 49057-1005 Ph: (269) 621-2166 |
News Archive
Connectyx Technologies Holdings Group, Inc. is pleased to announce that the Company is set to expand its market presence in the U.S. Electronic Health Record (EHR) Market. The EHR market is poised to grow at a rate of 13.5 percent over the next four years, and by 2015 it will top $4.85 billion, according to a new study by Kalorama Information.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that 28 CyberKnife-focused abstracts have been accepted as part of the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), taking place November 1 - 5 in Chicago, Illinois. This represents a 27 percent increase in CyberKnife abstracts over last year's Annual Meeting.
In research published in the August issue of Free Radical Biology and Medicine, U of T pharmacy and pharmacology professor Peter Wells and his colleagues determined that exposing pregnant mice only once to methamphetamine led to delivery of offspring with long-term neurodevelopmental problems, including reduced motor co-ordination.
Researchers at Georgetown University Medical Center have successfully used molecules comprised of small strands of RNA to shut down the production of destructive proteins generated by the COVID-19 virus.
› Verified 9 days ago